BAI to raise provisional reforms for more substituted dispensing

Published: 2004-10-12 06:59:00

Updated: 2004-10-12 06:59:00

The Board of Audit and Inspection of Korea (BAI) found that the post notification provision played as a main hampering constrain for pharmacies unable to actively exercise their substituted dispensing. The current post notification clause in the Pharmaceutical Affairs Act prescribes that any phar...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK